PhoreMost Achieves Second Milestone in Target Discovery Alliance with Boehringer Ingelheim 3rd June 2024
PhoreMost appoints Professor Peter Parker and Dr Jason Imbriglio to Scientific Advisory Board 17th July 2023
PhoreMost Reaches Milestone in a Target Discovery Alliance with Boehringer Ingelheim 5th January 2023
PhoreMost enters multi-target collaboration with targeted protein degradation leader Arvinas 28th October 2022